当前位置: 首页 > 期刊 > 《中国医学创新》 > 2025年第16期
编号:2390764
辛伐他汀联合尼莫地平对SAH后CVS患者氧化应激及炎症因子的影响
http://www.100md.com 2025年8月9日 中国医学创新 2025年第16期
     Effect Simvastatin Combined with Nimodipine on Oxidative Stress and Inflammatory Factors in Patients withCVSafterSAH/GUO Xiao,WU Zengbao.//Medical Innovation China,2025,22(16):063- 067

    [Abstract]Objective:To investigate the efect Simvastatin combined with Nimodipine on patients with cerebral vascular spasm (CVS)after subarachnoid hemorrhage (SAH).Method: A total 77 patients with CVS after SAHadmited to the Department Neurosurgery itional Chinese Medicine from September 2O21 to December 2O23 were included retrospectivelyand grouped in accordance with diffrent treatment modalities,the single group (n=38) was treated with Nimodipine,and the combined group ( n =39)was treated with Simvastatinonthe basis the single group.The clinical eficacy,inflammatory factors andoxidativestressindexes the two groups were compared. Result: After treatment, the total clinical effctive rate (94.87 % ) the combined group was higher than that ( 78.95% ) the single group,the difference was statistically significant ( P lt;0.05). Before treatment,there wereno significantdifferences inthelevels inflammatoryfactorsandoxidativestress indexes between the two groups ( P2 0.05);after treatment ......

您现在查看是摘要页,全文长 14134 字符